231 related articles for article (PubMed ID: 33017868)
1. Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples.
Ciarletto AM; Narick C; Malchoff CD; Massoll NA; Labourier E; Haugh K; Mireskandari A; Finkelstein SD; Kumar G
Cancer Cytopathol; 2021 Mar; 129(3):239-249. PubMed ID: 33017868
[TBL] [Abstract][Full Text] [Related]
2. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
[TBL] [Abstract][Full Text] [Related]
3. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
[TBL] [Abstract][Full Text] [Related]
4. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.
Finkelstein SD; Sistrunk JW; Malchoff C; Thompson DV; Kumar G; Timmaraju VA; Repko B; Mireskandari A; Evoy-Goodman LA; Massoll NA; Lupo MA
Thyroid; 2022 Nov; 32(11):1362-1371. PubMed ID: 35943886
[No Abstract] [Full Text] [Related]
6. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
[No Abstract] [Full Text] [Related]
7. Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.
Randolph GW; Sosa JA; Hao Y; Angell TE; Shonka DC; LiVolsi VA; Ladenson PW; Blevins TC; Duh QY; Ghossein R; Harrell M; Patel KN; Shanik MH; Traweek ST; Walsh PS; Yeh MW; Abdelhamid Ahmed AH; Ho AS; Wong RJ; Klopper JP; Huang J; Kennedy GC; Kloos RT; Sadow PM
Thyroid; 2022 Sep; 32(9):1069-1076. PubMed ID: 35793115
[No Abstract] [Full Text] [Related]
8. Diagnostic value and cost-effectiveness of FNA-CT versus FNAC for medullary thyroid carcinoma.
Wang M; Chen H; Wang Y; Lei J; Li Z
Clin Endocrinol (Oxf); 2023 May; 98(5):709-718. PubMed ID: 36394172
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
Shabani N; Razaviyan J; Paryan M; Tavangar SM; Azizi F; Mohammadi-Yeganeh S; Hedayati M
Hum Pathol; 2018 Sep; 79():212-221. PubMed ID: 29885402
[TBL] [Abstract][Full Text] [Related]
10. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.
Ogmen BE; Ince N; Aksoy Altınboga A; Akdogan L; Polat SB; Genc B; Menekse E; Aydin C; Topaloglu O; Ersoy R; Cakir B
Cancer Cytopathol; 2024 Mar; 132(3):161-168. PubMed ID: 37950525
[TBL] [Abstract][Full Text] [Related]
11. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
Liu Y; Yuan L; Yang D; Jin Y
Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
[TBL] [Abstract][Full Text] [Related]
12. Performing Calcitonin Immunocytochemistry on an Additional ThinPrep Slide in Fine-Needle Aspiration Diagnosis of Medullary Thyroid Carcinoma.
Ahmed M; Abi-Raad R; Fu L; Holt EH; Adeniran AJ; Cai G
Am J Clin Pathol; 2022 Mar; 157(3):426-433. PubMed ID: 34596209
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
[TBL] [Abstract][Full Text] [Related]
14. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region.
Liu CY; Bychkov A; Agarwal S; Zhu Y; Hang JF; Lai CR; Na HY; Li W; Liu Z; Jain D; Suzuki A; Hirokawa M; Chia N; Nga ME; Jitpasutham T; Keelawat S; Park SY; Satoh S; Chen CC; Gunawardena D; Kumarasinghe P; Jung CK; Kakudo K
Diagn Cytopathol; 2021 Jan; 49(1):60-69. PubMed ID: 32827355
[TBL] [Abstract][Full Text] [Related]
15. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
Viswanathan K; Behrman DB; Lubin DJ
Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
[TBL] [Abstract][Full Text] [Related]
16. Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
Workman AD; Soylu S; Kamani D; Nourmahnad A; Kyriazidis N; Saade R; Ren Y; Wirth L; Faquin WC; Onenerk AM; Nikiforov YE; Al-Qurayshi Z; Kandil E; Kloos RT; Eldeiry L; Lubitz C; Stathatos N; Randolph GW
Head Neck; 2021 Mar; 43(3):920-927. PubMed ID: 33269526
[TBL] [Abstract][Full Text] [Related]
17. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.
Chu YH; Lloyd RV
Endocr Pathol; 2016 Dec; 27(4):312-324. PubMed ID: 27539727
[TBL] [Abstract][Full Text] [Related]
18. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
Romeo P; Colombo C; Granata R; Calareso G; Gualeni AV; Dugo M; De Cecco L; Rizzetti MG; Zanframundo A; Aiello A; Carcangiu ML; Gloghini A; Ferrero S; Licitra L; Greco A; Fugazzola L; Locati LD; Borrello MG
Endocr Relat Cancer; 2018 Mar; 25(3):217-231. PubMed ID: 29298817
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
